180 related articles for article (PubMed ID: 10435799)
1. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
2. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
[No Abstract] [Full Text] [Related]
3. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
Mendenhall WM; Parsons JT
Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
Bentzen SM; Bernier J
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
[No Abstract] [Full Text] [Related]
5. Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of "evidence-based medicine".
Antognoni P; Corvò R; Zerini D; Orecchia R
Tumori; 2005; 91(1):30-9. PubMed ID: 15850002
[TBL] [Abstract][Full Text] [Related]
6. Altered fractionation radiotherapy in head and neck squamous cell carcinoma.
Mallick S; Benson R; Julka PK; Rath GK
J Egypt Natl Canc Inst; 2016 Jun; 28(2):73-80. PubMed ID: 26994645
[TBL] [Abstract][Full Text] [Related]
7. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
Stuschke M; Thames HD
Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801
[TBL] [Abstract][Full Text] [Related]
8. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
9. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
De Crevoisier R; Bourhis J; Eschwège F
Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
[No Abstract] [Full Text] [Related]
10. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck.
Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT
Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192
[TBL] [Abstract][Full Text] [Related]
11. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
12. Altered fractionation in the treatment of head and neck cancer.
Hu KS; Harrison LB
Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
[TBL] [Abstract][Full Text] [Related]
13. [For which tumor entities are effects of overall treatment time on the results of radiotherapy evident?].
Stuschke M; Marnitz S; Wurm R; Budach V
Strahlenther Onkol; 2000 Oct; 176(10):462-5. PubMed ID: 11068591
[TBL] [Abstract][Full Text] [Related]
14. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy in the management of early-stage head and neck cancer.
Hinerman RW; Mendenhall WM; Amdur RJ
Cancer Treat Res; 2003; 114():115-44. PubMed ID: 12619540
[No Abstract] [Full Text] [Related]
16. [The time factor in oncological therapy].
Baumann M; Herrmann T
Strahlenther Onkol; 2000 Oct; 176(10):441-2. PubMed ID: 11068586
[No Abstract] [Full Text] [Related]
17. Altered fractionation for head and neck cancer.
Garden AS
Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
19. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
20. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
